Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
New drug cocktail targets Hard-to-Treat myeloma spread
Disease control OngoingThis study tests a combination of four drugs (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) in 41 people with multiple myeloma that has spread outside the bones, known as extramedullary disease. The goal is to see how well the treatment works and how safe it is. P…
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
CAR-T therapy challenges stem cell transplant as First-Line treatment for multiple myeloma
Disease control OngoingThis phase 3 trial tests whether a new CAR-T cell therapy (cilta-cel) works better than the standard stem cell transplant for people newly diagnosed with multiple myeloma. About 759 participants will receive either CAR-T or a transplant after initial drug treatment. The main goal…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug cocktail aims to beat back multiple myeloma
Disease control OngoingThis phase 3 trial tests whether adding daratumumab to a standard three-drug regimen (VRd) improves outcomes for people with newly diagnosed multiple myeloma who can undergo high-dose therapy. About 709 participants will receive either the four-drug combo or the standard three dr…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC